Walgreens Boots Alliance Inc (NASDAQ:WBA) – Analysts at SunTrust Banks increased their FY2018 EPS estimates for shares of Walgreens Boots Alliance in a report issued on Thursday, Zacks Investment Research reports. SunTrust Banks analyst D. Macdonald now anticipates that the pharmacy operator will post earnings of $5.58 per share for the year, up from their previous estimate of $5.55. SunTrust Banks has a “Hold” rating and a $80.00 price objective on the stock. SunTrust Banks also issued estimates for Walgreens Boots Alliance’s Q1 2019 earnings at $1.40 EPS, Q3 2019 earnings at $1.55 EPS, Q4 2019 earnings at $1.45 EPS and FY2019 earnings at $6.05 EPS.
A number of other analysts have also recently commented on WBA. Royal Bank of Canada assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 target price on the stock. Jefferies Group reaffirmed a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Wednesday, September 20th. Raymond James Financial reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. BidaskClub lowered shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Tuesday, October 3rd. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Thursday, October 5th. Nine equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $86.20.
Shares of Walgreens Boots Alliance (NASDAQ WBA) traded down $0.25 during trading on Monday, reaching $75.78. 4,582,981 shares of the company’s stock were exchanged, compared to its average volume of 6,681,130. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The stock has a market cap of $75,050.00, a P/E ratio of 20.93, a P/E/G ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance has a fifty-two week low of $63.82 and a fifty-two week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.10 EPS.
Walgreens Boots Alliance announced that its board has approved a share buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.
In other news, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction dated Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of WBA. AQR Capital Management LLC increased its stake in shares of Walgreens Boots Alliance by 17.5% during the first quarter. AQR Capital Management LLC now owns 703,113 shares of the pharmacy operator’s stock valued at $58,394,000 after buying an additional 104,940 shares during the period. Shelton Capital Management raised its position in Walgreens Boots Alliance by 78.6% during the first quarter. Shelton Capital Management now owns 172,024 shares of the pharmacy operator’s stock valued at $14,287,000 after acquiring an additional 75,689 shares in the last quarter. Westwood Holdings Group Inc. purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $695,000. Tudor Investment Corp ET AL raised its position in Walgreens Boots Alliance by 11.7% during the first quarter. Tudor Investment Corp ET AL now owns 38,334 shares of the pharmacy operator’s stock valued at $3,184,000 after acquiring an additional 4,019 shares in the last quarter. Finally, Flagship Harbor Advisors LLC raised its position in Walgreens Boots Alliance by 0.5% during the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after acquiring an additional 16 shares in the last quarter. Hedge funds and other institutional investors own 61.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “SunTrust Banks Comments on Walgreens Boots Alliance Inc’s FY2018 Earnings (NASDAQ:WBA)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/17/walgreens-boots-alliance-inc-to-post-fy2018-earnings-of-5-58-per-share-suntrust-banks-forecasts-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.